BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 12917236)

  • 1. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
    Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E
    J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal Susceptibility of the Aspergillus viridinutans Complex: Comparison of Two
    Lyskova P; Hubka V; Svobodova L; Barrs V; Dhand NK; Yaguchi T; Matsuzawa T; Horie Y; Kolarik M; Dobias R; Hamal P
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal susceptibility of molecularly confirmed Aspergillus species from clinical samples.
    Tzar MN; Mustakim S; Yusoff H; Tap RM
    Malays J Pathol; 2024 Apr; 46(1):71-78. PubMed ID: 38682846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility testing of Aspergillus flavus: inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo.
    Mosquera J; Warn PA; Morrissey J; Moore CB; Gil-Lamaignere C; Denning DW
    Antimicrob Agents Chemother; 2001 May; 45(5):1456-62. PubMed ID: 11302810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B.
    Moore CB; Walls CM; Denning DW
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1882-5. PubMed ID: 11353643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic Aspergillus Strains Identification and Antifungal Susceptibility Analysis of 452 Cases with Otomycosis in Jingzhou, China.
    Peng D; Li A; Kong M; Mao C; Sun Y; Shen M
    Mycopathologia; 2024 Apr; 189(2):30. PubMed ID: 38578519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital distribution, seasonality, time trends and antifungal susceptibility profiles of all Aspergillus species isolated from clinical samples from 2015 to 2022 in a tertiary care hospital.
    Franconi I; Rizzato C; Ghelardi E; Lupetti A
    BMC Microbiol; 2024 Apr; 24(1):111. PubMed ID: 38570761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commercial Methods for Antifungal Susceptibility Testing of Saprophytic Molds: Can They Be Used to Detect Resistance?
    Paranos P; Espinel-Ingroff A; Meletiadis J
    J Fungi (Basel); 2024 Mar; 10(3):. PubMed ID: 38535222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against
    Melhem MSC; Coelho VC; Fonseca CA; Oliveira L; Bonfietti LX; Szeszs MW; Magri MMC; Dorneles FS; Taguchi H; Moreira DVS; Motta AL; Batista MV; Kamei K; Shikanai-Yasuda MA
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-examination of species limits in
    Sklenář F; Jurjević Ž; Houbraken J; Kolařík M; Arendrup MC; Jørgensen KM; Siqueira JPZ; Gené J; Yaguchi T; Ezekiel CN; Silva Pereira C; Hubka V
    Stud Mycol; 2021 Jun; 99():100120. PubMed ID: 35003383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal Susceptibility Testing: A Primer for Clinicians.
    Wiederhold NP
    Open Forum Infect Dis; 2021 Nov; 8(11):ofab444. PubMed ID: 34778489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can We Improve Antifungal Susceptibility Testing?
    Durand C; Maubon D; Cornet M; Wang Y; Aldebert D; Garnaud C
    Front Cell Infect Microbiol; 2021; 11():720609. PubMed ID: 34568095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal Susceptibility Testing: Current Approaches.
    Berkow EL; Lockhart SR; Ostrosky-Zeichner L
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32349998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potency of luliconazole against clinical and environmental
    Hivary S; Fatahinia M; Halvaeezadeh M; Mahmoudabadi AZ
    Iran J Microbiol; 2019 Dec; 11(6):510-519. PubMed ID: 32148683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal Susceptibly Testing by Concentration Gradient Strip Etest Method for Fungal Isolates: A Review.
    Dannaoui E; Espinel-Ingroff A
    J Fungi (Basel); 2019 Nov; 5(4):. PubMed ID: 31766762
    [No Abstract]   [Full Text] [Related]  

  • 16. (New) Methods for Detection of
    Jenks JD; Spiess B; Buchheidt D; Hoenigl M
    Curr Fungal Infect Rep; 2019 Sep; 13(3):129-136. PubMed ID: 31552129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
    Wang HC; Hsieh MI; Choi PC; Wu CJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Evaluation of Sensititre YeastOne and CLSI M38-A2 Reference Method for Antifungal Susceptibility Testing of Aspergillus spp. against Echinocandins.
    Siopi M; Pournaras S; Meletiadis J
    J Clin Microbiol; 2017 Jun; 55(6):1714-1719. PubMed ID: 28330883
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.